Clinical trials

At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.

Search for clinical trials by location and speciality

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Location: Adelaide, Brisbane, Perth, Melbourne, Mulgrave


30 October, 2019

Aortic Valve Stenosis

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk 

Location: Adelaide, Brisbane


30 October, 2019

Atrial Fibrillation

OPTION

To evaluate a new implantable device, the Watchman FLX in patients with non-valvular atrial fibrillation who have an increased stroke risk.

29 October, 2019

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Location: Adelaide, Brisbane, Perth, Bundaberg


22 August, 2019

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Location: Melbourne, Mulgrave, Brisbane


22 August, 2019

Heart Failure

HEART-FID

To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.

Location: Brisbane


To evaluate a new valve in patients with severe mitral regurgitation

Location: Adelaide, Brisbane, Melbourne, Perth


15 May, 2019

Heart Failure Device

COAST

To evaluate a new heart failure sensing device in patients with heart failure

Location: Brisbane


24 April, 2019

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Location: Melbourne, Brisbane


24 April, 2019

Cardiovascular disease and obesity

SELECT

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients

Location: Brisbane, Joondalup

Clinical Trials

At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Leabrook (Cardiology)

284 Kensington Road, Leabrook, SA 5068

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Murdoch (Cardiology)

St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Bundoora (Cardiology)

Health and Wellness Centre Level 1, Suites 8-10, 20 Scholar Drive, Bundoora, VIC, 3083

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Heidelberg (Cardiology)

Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084

Heart Failure and Cardiac Resynchronisation Therapy

SMART

A significant number of patients with heart failure implanted with a Cardiac Resynchronisation Therapy (CRT) device fail to respond to therapy. The cause of this non-response is yet to be determined.    The purpose of this study is to assess the pattern of electrical wiring of the heart, identify the variations seen in individuals with heart failure and their response to CRT. This study will also evaluate the link of CRT response to septal scar (heart scar tissue) and patterns of electrocardiogram (ECG). 

Mulgrave (Cardiology)

Mulgrave Private Hospital, Suite 8, Churchill Consulting Suites, Blanton Drive, Mulgrave, VIC, 3170

Aortic Valve Stenosis

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk 

Leabrook (Cardiology)

284 Kensington Road, Leabrook, SA 5068

Aortic Valve Stenosis

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk 

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Aortic Valve Stenosis

PORTICO-NG

To evaluate a new valve, the Portico™ NG Transcatheter Aortic Heart Valve, in patients who have symptomatic, severe aortic stenosis and are determined to be at high or extreme surgical risk 

Mater Brisbane (Cardiology)

Mater Private Clinic Suite 5.02 & 5.11, Level 5 550 Stanley Street South Brisbane QLD 4101

Atrial Fibrillation

OPTION

To evaluate a new implantable device, the Watchman FLX in patients with non-valvular atrial fibrillation who have an increased stroke risk.

Greenslopes (Cardiology)

Ramsay Specialist Centre Suite 212, Level 2 Newdegate Street, Greenslopes, QLD, 4120

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Leabrook (Cardiology)

284 Kensington Road, Leabrook, SA 5068

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Joondalup – Shenton House (Cardiology)

Level 3, Shenton House, 57 Shenton Avenue, Joondalup, WA 6027

Cardiovascular Disease

VESALIUS

To evaluate if treatment with additional cholesterol lowering medication reduces the risk of major cardiovascular events in patients at high cardiovascular risk

Friendly Society Private Hospital Bundaberg (Cardiology)

Floor 1, 19-23 Bingera Street, Bundaberg QLD 4670

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Heidelberg (Cardiology)

Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Bundoora (Cardiology)

Health and Wellness Centre Level 1, Suites 8-10, 20 Scholar Drive, Bundoora, VIC, 3083

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Mulgrave (Cardiology)

Mulgrave Private Hospital, Suite 8, Churchill Consulting Suites, Blanton Drive, Mulgrave, VIC, 3170

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Berwick (Cardiology)

Unit 2 / 11 Gloucester Avenue, Berwick VIC 3806

Cardio-Oncology

SUCCOUR MRI SUB-STUDY

To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Heart Failure

HEART-FID

To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

St Andrew's Medical Centre (Cardiology & Sleep Medicine)

St Andrew's Medical Centre Clinic, Level 2. 321 South Terrace, Adelaide, SA 5000

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Leabrook (Cardiology)

284 Kensington Road, Leabrook, SA 5068

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Doncaster East (Cardiology)

Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Heidelberg (Cardiology)

Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Perth Mount (Cardiology)

Suite 3, 140 Mounts Bay Road, Perth, WA 6000

Heart Failure due to mitral valve regurgitation

HighLife

To evaluate a new valve in patients with severe mitral regurgitation

Murdoch (Cardiology)

St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150

Heart Failure Device

COAST

To evaluate a new heart failure sensing device in patients with heart failure

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Berwick (Cardiology)

Unit 2 / 11 Gloucester Avenue, Berwick VIC 3806

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Doncaster East (Cardiology)

Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Mater Brisbane (Cardiology)

Mater Private Clinic Suite 5.02 & 5.11, Level 5 550 Stanley Street South Brisbane QLD 4101

Pericarditis

RHAPSODY

To evaluate a new medication for the treatment of recurrent pericarditis.

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Cardiovascular disease and obesity

SELECT

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients

Wesley Hospital Auchenflower (Cardiology)

Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066

Cardiovascular disease and obesity

SELECT

To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients

Joondalup Health Campus (Sleep Medicine)

Suite 103, Specialist Medical Centre West, Grand Blvd & Shenton Ave, Joondalup, WA, 6027